Literature DB >> 26933864

Invasive Candidiasis.

Bart Jan Kullberg, Maiken C Arendrup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26933864     DOI: 10.1056/NEJMc1514201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  Human inborn errors of immunity underlying superficial or invasive candidiasis.

Authors:  Anne Puel
Journal:  Hum Genet       Date:  2020-03-02       Impact factor: 4.132

2.  Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients.

Authors:  Süleyha Hilmioğlu-Polat; Somayeh Sharifynia; Yasemin Öz; Müge Aslan; Nuray Gündoğdu; Ayşe Serin; Haleh Rafati; Faezeh Mohammadi; Dilek Yeşim-Metin; Aylin Döğen; Macit Ilkit; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2018-05-03       Impact factor: 2.574

3.  Evaluation of the antifungal activity of α, β, and δ-damascone and inclusion complexes in β-cyclodextrin against Candida spp.

Authors:  Maria Rayane Correia de Oliveira; Maria Gabriely de Lima Silva; Antonia Thassya Lucas Dos Santos; Francisco Lucas Alves Batista; Roger Henrique Sousa da Costa; Anita Oliveira Brito Pereira Bezerra Martins; Beatriz Gonçalves da Cruz; Maria Flaviana Bezerra Morais-Braga; Henrique Douglas Melo Coutinho; Francisco Ernani Alves Magalhães; Diniz Maciel de Sena Junior; Alexandre Magno Rodrigues Teixeira; Irwin Rose Alencar de Menezes
Journal:  Folia Microbiol (Praha)       Date:  2022-02-03       Impact factor: 2.099

4.  Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis.

Authors:  Marie Warrer Petersen; Anders Perner; Fredrik Sjövall; Morten Hylander Møller
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

Review 5.  Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.

Authors:  Roeland E Wasmann; Eline W Muilwijk; David M Burger; Paul E Verweij; Catherijne A Knibbe; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

6.  Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity.

Authors:  Dayanira Alsina-Beauchamp; Alejandra Escós; Pilar Fajardo; Diego González-Romero; Ester Díaz-Mora; Ana Risco; Miguel A Martín-Serrano; Carlos Del Fresno; Jorge Dominguez-Andrés; Noelia Aparicio; Rafal Zur; Natalia Shpiro; Gordon D Brown; Carlos Ardavín; Mihai G Netea; Susana Alemany; Juan J Sanz-Ezquerro; Ana Cuenda
Journal:  EMBO Mol Med       Date:  2018-05       Impact factor: 14.260

7.  Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis.

Authors:  Zhidan Zhang; Ran Zhu; Zhenggang Luan; Xiaochun Ma
Journal:  BMJ Open       Date:  2020-07-12       Impact factor: 2.692

8.  Comprehensive genetic analysis of adhesin proteins and their role in virulence of Candida albicans.

Authors:  Sierra Rosiana; Liyang Zhang; Grace H Kim; Alexey V Revtovich; Deeva Uthayakumar; Arjun Sukumaran; Jennifer Geddes-McAlister; Natalia V Kirienko; Rebecca S Shapiro
Journal:  Genetics       Date:  2021-02-09       Impact factor: 4.562

9.  Candida albicans Yeast, Pseudohyphal, and Hyphal Morphogenesis Differentially Affects Immune Recognition.

Authors:  Liliane Mukaremera; Keunsook K Lee; Hector M Mora-Montes; Neil A R Gow
Journal:  Front Immunol       Date:  2017-06-07       Impact factor: 7.561

10.  Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data.

Authors:  Elizabeth A Lakota; Voon Ong; Shawn Flanagan; Christopher M Rubino
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.